Panneerselvam et al. [22] found that IL-24 could decrease the levels of miR-222-3p and -5p, thus increasing the target PPP2R2A level of miR-222, inhibiting the activation of protein kinase B (PKB, AKT), and inhibiting the expression of AKT in lung cancer cells. Here, AKT1 is linked to lung cancer.